Endocrine Deep Dives

Endocrine Deep Dives

By Gurbir Gill, MDEducationCourses
Download on the App Store

Endocrine Deep Dives episodes

  • Familial Partial Lipodystrophy

    Familial partial lipodystrophy mutations causing progressive subcutaneous fat loss from the extremities and trunk with paradoxical fat accumulation in the face and neck. This redistribution precipitates severe insulin resistance, hypertriglyceridemia, and premature cardiovascular disease. Diagnosis relies on physical examination recognizing characteristic fat loss patterns, genetic testing, and metabolic profiling. Management focuses on aggressive metabolic optimization, lifestyle modification, and targeted therapies for dyslipidemia and glycemic control to mitigate long-term cardiovascular and hepatic sequelae.


    20 min
  • Emil Theodor Kocher

    Emil Theodor Kocher revolutionized endocrine surgery by developing meticulous, sterile, and bloodless thyroidectomy techniques. His standardized operative methods reduced surgical mortality from nearly forty percent to under one percent. Kocher's precise documentation of cachexia strumipriva fundamentally delineated thyroid physiological function and postoperative myxedema, establishing the foundations of modern surgical endocrinology and safe neck exploration.


    27 min
  • Calcitonin

    Calcitonin, secreted by thyroid parafollicular C cells, acts as a physiological antagonist to parathyroid hormone by suppressing osteoclastic bone resorption and renal tubular calcium reabsorption. While minor in routine adult calcium homeostasis, serum calcitonin serves as an indispensable diagnostic and post-thyroidectomy surveillance biomarker for medullary thyroid carcinoma, directly correlating with tumor burden, staging, and systemic progression.


    25 min
  • Multiple Endocrine Neoplasia Type 1

    Multiple endocrine neoplasia type 1 arises from inactivating MEN1 tumor suppressor mutations, causing loss of menin function. Clinical manifestations classically feature primary hyperparathyroidism due to multiglandular hyperplasia, enteropancreatic neuroendocrine tumors, and anterior pituitary adenomas. Management prioritizes subtotal parathyroidectomy with transcervical thymectomy, specialized biochemical surveillance, and aggressive multi-phase imaging to detect malignant functional pancreatic lesions early.


    21 min
  • Crinecerfont for Steroid Reduction in CAH

    This episode evaluates crinecerfont, an oral corticotropin-releasing factor type 1 receptor antagonist, for classic congenital adrenal hyperplasia. By blocking pituitary ACTH secretion independently of glucocorticoid feedback, crinecerfont reduces adrenal androgen excess, including androstenedione. This mechanism permits significant supraphysiologic glucocorticoid dose reduction toward physiologic replacement levels, mitigating long-term iatrogenic metabolic and skeletal complications while preserving adrenal control.


    22 min
  • Billing Code G2211

    Explore the clinical implementation of add-on code G2211 for longitudinal endocrinology outpatient care. We analyze Centers for Medicare and Medicaid Services documentation requirements, medical decision-making thresholds, and audit vulnerabilities when capturing complex chronic disease management. Key takeaways include differentiating routine evaluation and management encounters from sustained, comprehensive continuity and structuring electronic health record workflows to ensure defensible reimbursement.


    17 min
  • Billing Code CGM/95251

    Analysis and interpretation of continuous glucose monitoring data requiring at least seventy-two hours of sensor wear. This physician service focuses on evaluating glycemic variability, time in range, and nocturnal hypoglycemia to refine therapy. Documentation requires a dedicated written interpretation addressing glycemic trends and actionable management changes, distinct from sensor placement and calibration procedures.



    18 min
  • XLH and Burosumab

    Adult presentations frequently masquerade as axial spondyloarthritis, early-onset osteoarthritis, or recurrent pseudofractures, evading diagnosis when chronic hypophosphatemia and renal phosphate wasting are overlooked. Transitioning from conventional therapy to the anti-FGF23 monoclonal antibody burosumab requires a mandatory washout of oral phosphate and active vitamin D to prevent hyperphosphatemia while restoring renal tubular reabsorption.


    21 min
  • COCPs for PMOS

    Combined oral contraceptives serve as first-line pharmacotherapy for non-fertility management. They suppress pituitary luteinizing hormone secretion to arrest ovarian theca-cell androgen synthesis while stimulating hepatic sex hormone-binding globulin production, drastically reducing bioactive free testosterone. This concurrent action mitigates hirsutism, restores cyclic withdrawal bleeding, and provides essential endometrial protection against unopposed estrogen-driven hyperplasia.

    25 min
  • Mixed Meal Tolerance Test

    A physiological dynamic assessment evaluating beta-cell secretory capacity and postprandial glycemic regulation under mixed macronutrient stimulation. Crucial for assessing residual endogenous insulin production via C-peptide in type 1 diabetes intervention trials, evaluating post-bariatric hypoglycemia, and differentiating hyperinsulinemic hypoglycemia etiologies where standard oral glucose fails to replicate native incretin and neural secretagogue responses.



    19 min

About Endocrine Deep Dives

From the publisher's feed

The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts.